Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Accumulated Expenses: 2018-2020

Historic Accumulated Expenses for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $11.7 million.

  • Black Diamond Therapeutics' Accumulated Expenses rose 161.61% to $21.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $21.5 million, marking a year-over-year increase of 161.61%. This contributed to the annual value of $11.7 million for FY2020, which is 302.90% up from last year.
  • According to the latest figures from FY2020, Black Diamond Therapeutics' Accumulated Expenses is $11.7 million, which was up 302.90% from $2.9 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Accumulated Expenses ranged from a high of $11.7 million in FY2020 and a low of $452,000 during FY2018.
  • Moreover, its 3-year median value for Accumulated Expenses was $2.9 million (2019), whereas its average is $5.0 million.
  • Data for Black Diamond Therapeutics' Accumulated Expenses shows a peak YoY soared of 541.37% (in 2019) over the last 5 years.
  • Over the past 3 years, Black Diamond Therapeutics' Accumulated Expenses (Yearly) stood at $452,000 in 2018, then soared by 541.37% to $2.9 million in 2019, then soared by 302.90% to $11.7 million in 2020.